Literature DB >> 22837023

The influence of surgery on quality of life in patients with intracranial meningiomas: a prospective study.

Asgeir S Jakola1, Michel Gulati, Sasha Gulati, Ole Solheim.   

Abstract

Meningiomas may influence both survival and neurological functions. Studies assessing the impact of surgery on health-related quality of life (HRQL) remain absent. In this prospective study we aimed to describe HRQL dynamics before and after surgery in patients with meningiomas. HRQL assessments were performed using EuroQol-5D (EQ-5D), a generic HRQL instrument. All adult patients with suspected intracranial meningioma from 2007 through 2011 were eligible for inclusion, and 54 patients were included after informed consent. All patients received a histopathological diagnosis of meningioma. The average preoperative EQ-5D index value (±SD) was 0.69 ± 0.26. The mean improvement 6 weeks after surgery was 0.06 (95 % CI, -0.03 to 0.16; p = 0.161) and the mean long term improvement was 0.09 (95 % CI, 0.00-0.17; p = 0.040). Surgery reduced pain/discomfort and anxiety/depression and improved the capability of performing usual activities. Clinically significant improvement at long-term assessment was noted in 25 patients (49 %) while a significant deterioration was reported in 10 patients (20 %). Patients who reported postoperative worsening of HRQL were also reporting better preoperative scores, suggesting a possible ceiling effect of EQ-5D in some of these patients. In our patients a modest average improvement in HRQL was seen after surgery for meningioma. About half of the patients reported a clinical important improvement at the late follow-up assessment. This improvement was mainly observed in the domains usual activities, pain/discomfort and anxiety/depression. However, one in five patients fared worse on late follow-up assessment, a figure of particular importance when treating asymptomatic meningiomas.

Entities:  

Mesh:

Year:  2012        PMID: 22837023     DOI: 10.1007/s11060-012-0947-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

1.  Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada.

Authors:  J A Johnson; A S Pickard
Journal:  Med Care       Date:  2000-01       Impact factor: 2.983

2.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 3.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

4.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

5.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

6.  Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas.

Authors:  Martin L Waagemans; David van Nieuwenhuizen; Monica Dijkstra; Miriam Wumkes; Clemens M F Dirven; Sieger Leenstra; Jaap C Reijneveld; Martin Klein; Lukas J A Stalpers
Journal:  Neurosurgery       Date:  2011-07       Impact factor: 4.654

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients.

Authors:  David van Nieuwenhuizen; Martin Klein; Lukas J A Stalpers; Sieger Leenstra; Jan J Heimans; Jaap C Reijneveld
Journal:  J Neurooncol       Date:  2007-04-13       Impact factor: 4.130

9.  Late neurocognitive sequelae in patients with WHO grade I meningioma.

Authors:  M Dijkstra; D van Nieuwenhuizen; L J A Stalpers; M Wumkes; M Waagemans; W P Vandertop; J J Heimans; S Leenstra; C M Dirven; J C Reijneveld; M Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-07-24       Impact factor: 10.154

10.  Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study.

Authors:  Asgeir S Jakola; Sasha Gulati; Clemens Weber; Geirmund Unsgård; Ole Solheim
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

View more
  14 in total

Review 1.  Neurosurgical oncology: advances in operative technologies and adjuncts.

Authors:  Randy S D'Amico; Benjamin C Kennedy; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2014-06-27       Impact factor: 4.130

2.  Meningioma recurrence rates following treatment: a systematic analysis.

Authors:  Victor Lam Shin Cheung; Albert Kim; Arjun Sahgal; Sunit Das
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

Review 3.  Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.

Authors:  Jaishri O Blakeley; Stephen Joel Coons; John R Corboy; Nancy Kline Leidy; Tito R Mendoza; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2016-03       Impact factor: 12.300

Review 4.  Impaired health-related quality of life in meningioma patients-a systematic review.

Authors:  Amir H Zamanipoor Najafabadi; Marthe C M Peeters; Linda Dirven; Daniel J Lobatto; Justus L Groen; Marieke L D Broekman; Saskia M Peerdeman; Wilo C Peul; Martin J B Taphoorn; Wouter R van Furth
Journal:  Neuro Oncol       Date:  2017-07-01       Impact factor: 12.300

5.  Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Authors:  Farshad Nassiri; Benjamin Price; Ameer Shehab; Karolyn Au; Michael D Cusimano; Michael D Jenkinson; Christine Jungk; Alireza Mansouri; Thomas Santarius; Suganth Suppiah; Ken X Teng; Gurvinder S Toor; Gelareh Zadeh; Tobias Walbert; Katharine J Drummond
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

6.  Is there a response shift in generic health-related quality of life 6 months after glioma surgery?

Authors:  Asgeir Store Jakola; Ole Solheim; Sasha Gulati; Lisa Millgård Sagberg
Journal:  Acta Neurochir (Wien)       Date:  2016-12-07       Impact factor: 2.216

Review 7.  Health-related quality of life of cranial WHO grade I meningioma patients: are current questionnaires relevant?

Authors:  Amir H Zamanipoor Najafabadi; Marthe C M Peeters; Daniel J Lobatto; Marieke L D Broekman; Timothy R Smith; Nienke R Biermasz; Saskia M Peerdeman; Wilco C Peul; Martin J B Taphoorn; Wouter R van Furth; Linda Dirven
Journal:  Acta Neurochir (Wien)       Date:  2017-09-27       Impact factor: 2.216

8.  Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study.

Authors:  Erik Thurin; Alba Corell; Sasha Gulati; Anja Smits; Roger Henriksson; J Bartek; Øyvind Salvesen; Asgeir Store Jakola
Journal:  Neurooncol Pract       Date:  2019-12-16

9.  Initial Gamma Knife Radiosurgery for Large or Documented Growth Asymptomatic Meningiomas: Long-Term Results From a 27-Year Experience.

Authors:  Junyi Fu; Lisha Wu; Chao Peng; Xin Yang; Hongji You; Linhui Cao; Yinhui Deng; Jinxiu Yu
Journal:  Front Oncol       Date:  2020-11-24       Impact factor: 6.244

10.  Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development.

Authors:  Haoyi Li; Huawei Huang; Xiaokang Zhang; Yonggang Wang; Xiaohui Ren; Yong Cui; Dali Sui; Song Lin; Zhongli Jiang; Guobin Zhang
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.